
Global Montelukast Sodium Tablet Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Montelukast Sodium Tablet market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Montelukast Sodium Tablet market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Montelukast Sodium Tablet market include Jiangsu Vanguard Pharmaceutical Co.,Ltd., Organon Pharma (UK) Limited, Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Taiwan Biotech Co., Ltd, Sandoz Private Limited and N.V. Organon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Montelukast Sodium Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Montelukast Sodium Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Sodium Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Montelukast Sodium Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Montelukast Sodium Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Montelukast Sodium Tablet sales, projected growth trends, production technology, application and end-user industry.
Montelukast Sodium Tablet Segment by Company
Jiangsu Vanguard Pharmaceutical Co.,Ltd.
Organon Pharma (UK) Limited
Lunan Better Pharmaceutical Co.,Ltd
Otsuka
Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
Taiwan Biotech Co., Ltd
Sandoz Private Limited
N.V. Organon
Montelukast Sodium Tablet Segment by Type
Original Drug
Generic Drug
Montelukast Sodium Tablet Segment by Application
Hospital
Pharmacy
Others
Montelukast Sodium Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Montelukast Sodium Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Montelukast Sodium Tablet market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Montelukast Sodium Tablet significant trends, drivers, influence factors in global and regions.
6. To analyze Montelukast Sodium Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Montelukast Sodium Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium Tablet industry.
Chapter 3: Detailed analysis of Montelukast Sodium Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Montelukast Sodium Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Montelukast Sodium Tablet in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Montelukast Sodium Tablet market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Montelukast Sodium Tablet market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Montelukast Sodium Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Montelukast Sodium Tablet market include Jiangsu Vanguard Pharmaceutical Co.,Ltd., Organon Pharma (UK) Limited, Lunan Better Pharmaceutical Co.,Ltd, Otsuka, Shanghai Anbisheng Pharmaceutical Technology Co. Ltd, Taiwan Biotech Co., Ltd, Sandoz Private Limited and N.V. Organon, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Montelukast Sodium Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Montelukast Sodium Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Sodium Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Montelukast Sodium Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Montelukast Sodium Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Montelukast Sodium Tablet sales, projected growth trends, production technology, application and end-user industry.
Montelukast Sodium Tablet Segment by Company
Jiangsu Vanguard Pharmaceutical Co.,Ltd.
Organon Pharma (UK) Limited
Lunan Better Pharmaceutical Co.,Ltd
Otsuka
Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
Taiwan Biotech Co., Ltd
Sandoz Private Limited
N.V. Organon
Montelukast Sodium Tablet Segment by Type
Original Drug
Generic Drug
Montelukast Sodium Tablet Segment by Application
Hospital
Pharmacy
Others
Montelukast Sodium Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Montelukast Sodium Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Montelukast Sodium Tablet market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Montelukast Sodium Tablet significant trends, drivers, influence factors in global and regions.
6. To analyze Montelukast Sodium Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Montelukast Sodium Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Montelukast Sodium Tablet industry.
Chapter 3: Detailed analysis of Montelukast Sodium Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Montelukast Sodium Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Montelukast Sodium Tablet in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
192 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Montelukast Sodium Tablet Sales Value (2020-2031)
- 1.2.2 Global Montelukast Sodium Tablet Sales Volume (2020-2031)
- 1.2.3 Global Montelukast Sodium Tablet Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Montelukast Sodium Tablet Market Dynamics
- 2.1 Montelukast Sodium Tablet Industry Trends
- 2.2 Montelukast Sodium Tablet Industry Drivers
- 2.3 Montelukast Sodium Tablet Industry Opportunities and Challenges
- 2.4 Montelukast Sodium Tablet Industry Restraints
- 3 Montelukast Sodium Tablet Market by Company
- 3.1 Global Montelukast Sodium Tablet Company Revenue Ranking in 2024
- 3.2 Global Montelukast Sodium Tablet Revenue by Company (2020-2025)
- 3.3 Global Montelukast Sodium Tablet Sales Volume by Company (2020-2025)
- 3.4 Global Montelukast Sodium Tablet Average Price by Company (2020-2025)
- 3.5 Global Montelukast Sodium Tablet Company Ranking (2023-2025)
- 3.6 Global Montelukast Sodium Tablet Company Manufacturing Base and Headquarters
- 3.7 Global Montelukast Sodium Tablet Company Product Type and Application
- 3.8 Global Montelukast Sodium Tablet Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Montelukast Sodium Tablet Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Montelukast Sodium Tablet Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Montelukast Sodium Tablet Market by Type
- 4.1 Montelukast Sodium Tablet Type Introduction
- 4.1.1 Original Drug
- 4.1.2 Generic Drug
- 4.2 Global Montelukast Sodium Tablet Sales Volume by Type
- 4.2.1 Global Montelukast Sodium Tablet Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Montelukast Sodium Tablet Sales Volume by Type (2020-2031)
- 4.2.3 Global Montelukast Sodium Tablet Sales Volume Share by Type (2020-2031)
- 4.3 Global Montelukast Sodium Tablet Sales Value by Type
- 4.3.1 Global Montelukast Sodium Tablet Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Montelukast Sodium Tablet Sales Value by Type (2020-2031)
- 4.3.3 Global Montelukast Sodium Tablet Sales Value Share by Type (2020-2031)
- 5 Montelukast Sodium Tablet Market by Application
- 5.1 Montelukast Sodium Tablet Application Introduction
- 5.1.1 Hospital
- 5.1.2 Pharmacy
- 5.1.3 Others
- 5.2 Global Montelukast Sodium Tablet Sales Volume by Application
- 5.2.1 Global Montelukast Sodium Tablet Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Montelukast Sodium Tablet Sales Volume by Application (2020-2031)
- 5.2.3 Global Montelukast Sodium Tablet Sales Volume Share by Application (2020-2031)
- 5.3 Global Montelukast Sodium Tablet Sales Value by Application
- 5.3.1 Global Montelukast Sodium Tablet Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Montelukast Sodium Tablet Sales Value by Application (2020-2031)
- 5.3.3 Global Montelukast Sodium Tablet Sales Value Share by Application (2020-2031)
- 6 Montelukast Sodium Tablet Regional Sales and Value Analysis
- 6.1 Global Montelukast Sodium Tablet Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Montelukast Sodium Tablet Sales by Region (2020-2031)
- 6.2.1 Global Montelukast Sodium Tablet Sales by Region: 2020-2025
- 6.2.2 Global Montelukast Sodium Tablet Sales by Region (2026-2031)
- 6.3 Global Montelukast Sodium Tablet Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Montelukast Sodium Tablet Sales Value by Region (2020-2031)
- 6.4.1 Global Montelukast Sodium Tablet Sales Value by Region: 2020-2025
- 6.4.2 Global Montelukast Sodium Tablet Sales Value by Region (2026-2031)
- 6.5 Global Montelukast Sodium Tablet Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Montelukast Sodium Tablet Sales Value (2020-2031)
- 6.6.2 North America Montelukast Sodium Tablet Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Montelukast Sodium Tablet Sales Value (2020-2031)
- 6.7.2 Europe Montelukast Sodium Tablet Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Montelukast Sodium Tablet Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Montelukast Sodium Tablet Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Montelukast Sodium Tablet Sales Value (2020-2031)
- 6.9.2 South America Montelukast Sodium Tablet Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Montelukast Sodium Tablet Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Montelukast Sodium Tablet Sales Value Share by Country, 2024 VS 2031
- 7 Montelukast Sodium Tablet Country-level Sales and Value Analysis
- 7.1 Global Montelukast Sodium Tablet Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Montelukast Sodium Tablet Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Montelukast Sodium Tablet Sales by Country (2020-2031)
- 7.3.1 Global Montelukast Sodium Tablet Sales by Country (2020-2025)
- 7.3.2 Global Montelukast Sodium Tablet Sales by Country (2026-2031)
- 7.4 Global Montelukast Sodium Tablet Sales Value by Country (2020-2031)
- 7.4.1 Global Montelukast Sodium Tablet Sales Value by Country (2020-2025)
- 7.4.2 Global Montelukast Sodium Tablet Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.9.2 France Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.16.2 China Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.19.2 India Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Montelukast Sodium Tablet Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Montelukast Sodium Tablet Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Montelukast Sodium Tablet Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Jiangsu Vanguard Pharmaceutical Co.,Ltd.
- 8.1.1 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Comapny Information
- 8.1.2 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Business Overview
- 8.1.3 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Montelukast Sodium Tablet Product Portfolio
- 8.1.5 Jiangsu Vanguard Pharmaceutical Co.,Ltd. Recent Developments
- 8.2 Organon Pharma (UK) Limited
- 8.2.1 Organon Pharma (UK) Limited Comapny Information
- 8.2.2 Organon Pharma (UK) Limited Business Overview
- 8.2.3 Organon Pharma (UK) Limited Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Organon Pharma (UK) Limited Montelukast Sodium Tablet Product Portfolio
- 8.2.5 Organon Pharma (UK) Limited Recent Developments
- 8.3 Lunan Better Pharmaceutical Co.,Ltd
- 8.3.1 Lunan Better Pharmaceutical Co.,Ltd Comapny Information
- 8.3.2 Lunan Better Pharmaceutical Co.,Ltd Business Overview
- 8.3.3 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Lunan Better Pharmaceutical Co.,Ltd Montelukast Sodium Tablet Product Portfolio
- 8.3.5 Lunan Better Pharmaceutical Co.,Ltd Recent Developments
- 8.4 Otsuka
- 8.4.1 Otsuka Comapny Information
- 8.4.2 Otsuka Business Overview
- 8.4.3 Otsuka Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.4.4 Otsuka Montelukast Sodium Tablet Product Portfolio
- 8.4.5 Otsuka Recent Developments
- 8.5 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd
- 8.5.1 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Comapny Information
- 8.5.2 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Business Overview
- 8.5.3 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Montelukast Sodium Tablet Product Portfolio
- 8.5.5 Shanghai Anbisheng Pharmaceutical Technology Co. Ltd Recent Developments
- 8.6 Taiwan Biotech Co., Ltd
- 8.6.1 Taiwan Biotech Co., Ltd Comapny Information
- 8.6.2 Taiwan Biotech Co., Ltd Business Overview
- 8.6.3 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Taiwan Biotech Co., Ltd Montelukast Sodium Tablet Product Portfolio
- 8.6.5 Taiwan Biotech Co., Ltd Recent Developments
- 8.7 Sandoz Private Limited
- 8.7.1 Sandoz Private Limited Comapny Information
- 8.7.2 Sandoz Private Limited Business Overview
- 8.7.3 Sandoz Private Limited Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Sandoz Private Limited Montelukast Sodium Tablet Product Portfolio
- 8.7.5 Sandoz Private Limited Recent Developments
- 8.8 N.V. Organon
- 8.8.1 N.V. Organon Comapny Information
- 8.8.2 N.V. Organon Business Overview
- 8.8.3 N.V. Organon Montelukast Sodium Tablet Sales, Value and Gross Margin (2020-2025)
- 8.8.4 N.V. Organon Montelukast Sodium Tablet Product Portfolio
- 8.8.5 N.V. Organon Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Montelukast Sodium Tablet Value Chain Analysis
- 9.1.1 Montelukast Sodium Tablet Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Montelukast Sodium Tablet Sales Mode & Process
- 9.2 Montelukast Sodium Tablet Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Montelukast Sodium Tablet Distributors
- 9.2.3 Montelukast Sodium Tablet Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.